A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation is a research paper published in Molecular Therapy (2023). On theSindex it has a DataRank of 0.604. It has been cited 55 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.604
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Allergy and Infectious Diseases
Grant: 75N93019C00008
National Institute of Allergy and Infectious Diseases
Grant: R61AI161811
National Institute of Allergy and Infectious Diseases
Grant: 75N93019C00037
National Institute of Allergy and Infectious Diseases
Grant: 1R43AI165100-01
Development of an adaptable RNA vaccine against enterovirus D68 infection for the prevention of acute flaccid myelitis
National Institute of Allergy and Infectious Diseases
Grant: 75N93020C00028
National Institute of Allergy and Infectious Diseases
Grant: 62/993,307
NIAID NIH HHS
Grant: R43 AI165100
National Institutes of Health
Grant: 1R61AI161811-01
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
National Institutes of Health
FWCI
5.20
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals